Imatinib Mesylate

Molecular Weight589.7 g/mol

HS Code29349900

SmellOther, Odorless

Boiling pointNot applicable (decomposes)

EINECS NoNot assigned

Particle Size90% pass through 60 mesh

MOQ50 Box/Boxes

Pacakaging (Quantity Per Box)10 strips per box

Salt CompositionImatinib Mesylate

Origin of MedicineSynthetic

Drug TypeOther, Anticancer Drug

IngredientsImatinib Mesylate

Physical FormTablet, Other

MOQ1000 Box/Boxes

GradePharma

AppearanceTablet

StorageStore in a Cool & Dry Place

DosageAs Directed By Physician

Assay99.5%

CAS Number220127-57-1

Chemical FormulaC29H31N7O.CH4O3S

FeaturesCancer treatment, Tyrosine kinase inhibitor, High purity, Effective dosage, Reliable source

Melting Point214-224 °C

Molecular Weight589.71

MOQ1130 Box/Boxes

Origin of MedicineINDIA

Physical FormCapsules

Recommended ForDOCTOR

Quantity1130 Strip

MOQ100000 Tablet

Dosage FormTablets

IndicationChronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), Gastrointestinal Stromal Tumors (GIST)

Salt CompositionImatinib Mesylate

FeatureOther, Film-coated, easy to swallow

IngredientsOther , Imatinib Mesylate, Excipients

ApplicationOther, Cancer Treatment

MOQ10 Box/Boxes

GradePharmaceutical Grade

Dosage FormCapsule

OriginIndia

Enzyme TypesOther, Mesylate Capsules

Formulations TypeMedicine Raw Materials

Formulations FormTablets

MOQ1 Box/Boxes

Drug TypeGeneric Drugs

Formulations TypeGeneral Drugs

Formulations FormTablets

Physical FormTablets

ApplicationOther

Storage Instructionscool and dry place

Dosage400 mg

Drug NameImatinib Mesylate

FeaturesCancer treatment, Tumor reduction, Disease management, Improved survival

FormTablets

PackagingBlister pack

Route of AdministrationOral

AppearanceWhite to off-white crystalline powder

CAS No222006-62-4

Chemical FormulaC29H31N7O

FeaturesCancer treatment, Targeted therapy, Effective, Safe dosage, Improved survival

IUPAC NAMEN-(2-chloro-6-methylphenyl)-4-[(4-methylpiperazin-1-yl)methyl]-2-(phenylamino)pyrimidine-5-carboxamide mesylate

Melting Point215-218°C

MOQ100 Pack/Packs

Drug TypeGeneral Medicines

Physical FormTablets

Recommended ForChronic myeloid leukaemia (CML) and GIST

Dosage400 mg

Dosage GuidelinesAs per suggestion

Storage InstructionsDry Place

MOQ1 Kilograms/Kilograms

StorageRoom Temperature

Shelf Life5 Years

Medicine NameImatinib mesylate API Powder BP

Chemical NameImatinib mesylate API Powder BP

CAS No220127-57-1

TypePharmaceutical Intermediates

MOQ5 Strip/Strips

Pacakaging (Quantity Per Box)10 x 10 tablets

Origin of MedicineImported

Dosage FormSolid (Oral Tablet)

IndicationChronic myeloid leukemia (CML), Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), Gastrointestinal stromal tumors (GIST)

Salt CompositionImatinib Mesylate 400mg

Drug TypeOther, Prescription

MOQ1 Bottle/Bottles

Drug TypeGeneral Medicines

IngredientsImatinib Mesylate Tablets are prescribed for treatment of cancer specifically CML, CLL, and certain types of gastrointestinal stromal tumors. They are anti-neoplastic agents that are considered as tyrosine kinase inhibitors

Physical FormTablets

FunctionCancer Treatment

Recommended ForAS PER PHYSICIAN

DosageAS PER PHYSICIAN

MOQ1 Ton/Tons

StorageRoom Temperature

Other NamesOsimertinib Mesylate(AZD9291)

CAS No1421373-66-1

GradeMedicine Grade

ApplicationPharmaceutical Industry

FormSolid